{
  "id": 10788162,
  "title": "Aterian announces change in control, board appointment, and CVR payment",
  "url": "https://urgent.news/2026/09/29/aterian-announces-change-in-control-board-appointment-and-cvr-payment",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-29T21:43:04.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/sec-filings/aterian-announces-change-in-control-board-appointment-and-cvr-payment-93CH-4923727"
  },
  "original_language": "en",
  "account": "Aterian, Inc. (NASDAQ: ATER) has announced significant changes in control, board appointments, and a contingent value rights (CVR) payment. On September 25, David E. Lazar sold his interests in $12 million worth of preferred shares, reducing his ownership from a controlling stake to about 3.1%. Avraham Ben-Tzvi resigned from the board and all committees, while William H. Crampton was appointed as a new board member and member of the Audit and Compensation Committees. Aterian also granted Crampton an initial restricted stock award of 301,205 shares and agreed to a $150,000 retention bonus for Lazar. The contingent value rights agreement will result in a cash payment of approximately $0.9936 per CVR holder on October 2. Despite facing challenging financial conditions, Aterian reported $68.85 million in revenue over the past year with a 35% growth rate. The company holds more cash than debt and maintains a WEAK overall financial health score. Aterian is scheduled to hold a Special Meeting of Stockholders to discuss proposals such as an $18 million asset sale and a $7 million financing transaction.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}